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Abstract
Human pluripotent stem cells (hPSC) hold great promise as models for understanding disease and as a source of cells for
transplantation therapies. However, the lack of simple, robust and efficient culture methods remains a significant obstacle
for realizing the utility of hPSCs. Here we describe a platform for the culture of hPSCs that 1) allows for dissociation and
replating of single cells, 2) significantly increases viability and replating efficiency, 3) improves freeze/thaw viability 4)
improves cloning efficiency and 5) colony size variation. When combined with standard methodologies for genetic
manipulation, we found that the enhanced culture platform allowed for lentiviral transduction rates of up to 95% and
electroporation efficiencies of up to 25%, with a significant increase in the total number of antibiotic-selected colonies for
screening for homologous recombination. We further demonstrated the utility of the enhanced culture platform by
successfully targeting the ISL1 locus. We conclude that many of the difficulties associated with culturing and genetic
manipulation of hPSCs can be addressed with optimized culture conditions, and we suggest that the use of the enhanced
culture platform could greatly improve the ease of handling and general utility of hPSCs.
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Introduction
Since the derivation of human embryonic stem cells [1], their
growth and maintenance in culture have remained challenging.
When compared to mouse pluripotent stem cells (mPSCs), the
human counterparts (hPSCs) are less robust, more prone to
spontaneous differentiation, difficult to culture as single cells, and
less amenable to genetic manipulation. With the generation of
human induced pluripotent stem cells [2–4], there has been
increased interest in the use of hPSCs for a variety of applications.
Recently, the introduction of defined media conditions, feeder-free
culture systems, and chemicals to facilitate survival of hPSCs as
single cells [5–7] have led to significant improvements, yet an
efficient and robust culture methodology has been lacking.
We used a combination of recently published hPSC culture
protocols and their further optimization to develop a protocol that
we term the enhanced culture platform (ECP). We extensively
evaluated this platform and compared it to one of the more widely
used culture method, here termed the standard culture platform
(SCP). We developed multiple lines of evidence that culturing
hPSCs using the ECP significantly facilitates their handling and
genetic manipulation. Use of the ECP maintained the pluripo-
tency and genetic integrity of hPSCs over long-term culturing and
passaging. The ECP improved replating efficiencies and viability
of single-cells when passaging hPSCs. This culture platform also
increased the viability of hPSCS after freezing and thawing.
Importantly, the ECP yielded higher clonogenic efficiency,
increased transduction by lentiviral vectors, and improved
electroporation efficiencies of hPSCs. Finally, we were readily
able to perform homologous recombination using the ECP. Thus,
the use of the ECP for growth, maintenance, and manipulation of
hPSCs provides a robust and efficient culture methodology that
promises to improve the utility of hPSCs.
Results and Discussion
The ECP was the combination of a feeder free culture system
utilizing Geltrex [5], TeSR defined media [7], Accutase [8] to
dissociate and detach cells and Rock-Inhibitor (Y-27632) [6] to
stabilize the subsequent intermediate single cell state. This culture
platform was extensively evaluated and compared to the standard
culture platform (SCP) of hPSCs in feeder free conditions,
consisting of a combination of Geltrex, TeSR and Dispase.
In order to establish that the ECP was capable of maintaining
the pluripotency and genetic integrity of hPSCs over extended
culturing, we passaged HUES9 [9] and BJ-RiPSC [10] cells over
15 times using the ECP. Throughout this culture period, the cells
maintained well-defined, phase-bright borders, a high nucleus-to-
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the cells immunohistochemically for markers of pluripotency
including OCT4, SOX2, NANOG and TRA-1-81 (Figure S1A)
and found them to be positive for each of the markers. We also
confirmed high expression of two master regulators of pluripo-
tency, OCT4 and NANOG, in cells grown using the ECP by
quantitative reverse transcription followed by polymerase chain
reaction (qRT-PCR) amplification (Figure S1B). We also found
that cells of both lines grown using the ECP for more than 15
passages formed teratomas comprising all three embryonic germ
layers (Figure S1C) and remained karyotypically normal (Figure
S1D).
We next compared the ECP to a well-established culture
methodology (SCP) with respect to the ease of handling and
maintaining hPSCs in culture. We first determined the percentage
of cells reattaching after passage (often referred to as the replating
efficiency) using three human embryonic stem cell (hESC) lines
and two human induced pluripotent stem cell (hiPSC) lines and
found a significant increase (p=2610
26) from an average 23%
(SCP) to 85% (ECP) of cells that replated and remained viable
(Figure 1A). As a consequence, we were able to dilute the standard
split ratio of 1:4 with the SCP to as much as a 1:15 ratio with the
ECP, allowing for more rapid expansion of hPSCs. We next
sought to determine if the ECP might also improve the viability of
hPSCs after freezing and thawing (Figure 1B). In all 5 hPSC lines,
the percentage of viable cells recovered after freezing and thawing
significantly improved (p=2610
26) from an average of 10%
(SCP) to an average of 65% (ECP). The ability to quickly expand
hPSCs in culture using the ECP as well as quickly create large
stocks of viable frozen cells should thereby reduce the time
necessary to set up experiments, as well as reduce the total time in
culture for hPSCs as they are prepared for experiments.
To investigate the clonogenic potential of hPSCs grown with the
ECP, the cloning efficiency in three hPSC lines was determined by
limiting dilution (Figure 1C). We found that an average of 4% of
plated single cells grown in SCP were able to form clonogenic
colonies in comparison to almost 70% grown using the ECP
(p=0.002). As the Rho Associated Kinase (ROCK) Inhibitor (Y-
27632) has been previously shown to stabilize the hESC single-cell
state [6,11] and is a component of the ECP, a series of experiments
were performed to determine the effect of ROCK-Inhibitor in the
ECP (Figure S2). While inclusion of ROCK-Inhibitor improved
the replating, freeze/thaw, and cloning efficiency of hPSCs, most
of the improvement observed with the ECP appeared to be due to
the combination of the newly introduced culture techniques rather
than the addition of the chemical.
With routine use of the ECP, we made two additional
observations. First, dissociation of hPSCs to single cells resulted
in more uniform colony sizes. We quantified the colony size
distribution by measuring the surface area of 150 colonies three
days after passage with either the ECP or the SCP and found a
reduction in variability with the ECP (Figure 1D). Second, we
observed an increase in the proportion of Tra-1-60 positive cells in
culture over three passages (Figure 1E). We quantified this
observation by measuring TRA-1-60 via flow cytometry using
two hPSC lines that had a relatively high percentage of TRA-1-60
negative cells admixed in culture (42% in HUES1 and 47% in BJ
RiPSC). After repeated passaging using the SCP, both hPSC lines
showed a marked decrease in the amount of TRA1-60-positive
cells [HUES1: 58% in passage 0 (p0) to 40% in passage 3 (p3); BJ
RiPSC: 53% in p0 to 12% in p3]. In contrast, hPSCs cultured
using the ECP increased the percentage of TRA-1-60-positive cells
over time (HUES1: 58% in p0 to 66% in p3; BJ RiPSC: 53% in p0
to 58% in p3). As hPSCs are known to fluctuate in their expression
of cell surface markers such as TRA-1-60, this observation may
not correspond to an increase in the number of pluripotent cells
when cultured with the ECP. In order to determine if the ECP
does in fact reduce the proportion of non-pluripotent cells over
time additional markers of pluripotency would need to be assessed
over a much longer period of time in culture (i.e. 10 passages or
more). The increased proportion of TRA-1-60 positive hPSCs
together with the reduced colony size variation, may further
reduce variability and improve standardization and reproducibility
of experiments with hPSCs.
We next sought to evaluate the ECP using two standard
methods of genetic manipulation, lentiviral transduction and gene
targeting. Lentiviral transduction has been previously reported in
hPSCs using ultra-concentrated virus [12], although the reported
efficiency in hPSCs remained relatively low (70%–80%) as
compared to several other cell types in which transduction
efficiencies of 100% can be routinely achieved without ultra-
concentrating the virus. Upon transduction of hPSCs grown using
the SCP with lentiviral particles designed to constitutively express
green fluorescent protein (LV-GFP), GFP-positive cells were found
predominantly at the borders of hPSC colonies. In contrast,
hPSCs grown in the ECP and subsequently transduced with LV-
GFP displayed GFP-positive cells throughout the hPSC colonies
(Figure 2A). To quantify the overall efficiency of lentiviral
transduction, four hPSC lines grown with either the SCP or the
ECP were transduced with LV-GFP using a range of viral particle
concentrations, and the percentage of GFP-positive cells was
evaluated via flow cytometry (Figure 2B). A significant increase
(p=0.03) in transduction efficiency was observed in hPSCs grown
with the ECP (96%) as compared to cells grown with the SCP
(54%). In all of the four hPSC lines tested, the transduction
efficiencies exceeded 95% with the use of ECP and without the
need for ultra-concentration of the virus. The introduction of
overexpression and knockdown constructs via lentivirus with
greater than 95% efficiency should allow for the routine
establishment of hPSC populations that homogenously express
the desired factors without the need for selection strategies.
Finally, we investigated the utility of the ECP for the delivery of
plasmids into hPSCs via electroporation for homologous recom-
bination (HR). We first determined the viability of cells
electroporated using either the ECP or the SCP and found a
significantly increased (p=0.002) viability of the cells electropo-
rated with the ECP, with an average of 69% surviving the
procedure (Figure 2D top). Additionally, the overall percentage of
cells that transiently expressed GFP from an electroporated
plasmid significantly improved (p=0.004) from an average of
7.4% (SCP) to 20% (ECP) (Figure 2D middle), thus allowing for a
more than 20-fold increase of the total number of viable GFP-
positive cells from 0.64% to 13.91% of the initial number of cells.
We then attempted to duplicate the previously reported targeting
by HR of the ISL1 locus [13]. After a single electroporation of
1610
6 cells, 3,320 colonies of HUES9 cells and 2,750 colonies of
BJ RiPSC cells were obtained after antibiotic selection (Figure 2F).
We evaluated 85 of the BJ RiPSC colonies for HR via long-range
PCR and found one successful event (Figure 2G). The efficiency of
HR at this locus with the ECP (1.17%) was comparable to what
had been previously reported (1.42%). Thus, the recombination
frequency at the locus does not appear to change with alteration of
culture conditions, but use of the ECP allows for highly efficient
target construct delivery and, given the increase in the number of
colonies available for screening, should thereby facilitate gene
targeting.
In conclusion, the ECP allows for dissociation and replating of
single hPSCs, significantly increases viability and replating
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efficiency of hPSCs. The growth of hPSCs with the ECP also
reduced colony size variation and might further reduce the
proportion of spontaneously arising non-pluripotent cells. When
combined with standard methodologies for genetic manipulation,
we found that the enhanced culture platform allowed for lentiviral
Figure 1. Comparing cell culture of hPSCs using the standard (SCP) or the enhanced culture platform (ECP). A) Quantification of cells
reattached 2 h after passage in a total of 5 cell lines either using the SCP or ECP to passage the cells (n=3 per cell line, standard error, p=1.68
206).
B) Quantification of cells reattached after being frozen in liquid nitrogen for 7–10 d and subsequently thawed (n=3 per cell line, standard error,
p=1.69
206). C) To determine the clonogenic potential, a limiting dilution assay on a total of 3 cell lines was performed (96 cell plated per cell line,
standard error, p=0.002). Counted were only colonies with positive immunoflourescence staining for the pluripotency markers OCT3/4 and NANOG.
D) Colony size distribution in mm, 3 days after passage with either the SCP or ECP (n=150 colonies each). E) Representative images of BJ RiPSC
colonies before and after being passaged 3 times with SCP or ECP respectively (black arrows indicates differentiated, non-pluripotent cells) and
quantification of the change via flow cytometry utilizing TRA1-60 as a pluripotency marker.
doi:10.1371/journal.pone.0027495.g001
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up to 25%, with a significant increase in the total number of
antibiotic-resistant colonies. Thus, the growth, maintenance, and
manipulation of hPSCs with the ECP significantly facilitates the
ease of utilizing hPSCs and should ultimately facilitate many
applications of hPSC research.
Figure 2. Comparing genetic manipulation efficiencies of hPSCs using either the standard (SCP) or the enhanced culture platform
(ECP). A) Fluorescence image of Lentiviral transduction with an LV-GFP reporter indicate differences in efficiency and distribution of GFP+ cells
(lentivirus copy number 5610
+06 per 30.000cells). B) Quantification of lentiviral transduction efficiency via flow cytometry towards the LV-GFP
reporter with various lentivirus copy numbers (30.000 cells per setup) in 4 different cell lines (standard error, p=0.03; cell lines: HUES6, HUES9, CF
RiPSC and BJ RiPSC). C) Representative flow cytometry plot for HUES6 lentiviral transduction efficiency. D) Average efficiency of an EP-GFP reporter
plasmid delivered into the HUES9 line via electroporation. The top bars indicate the amount of cells surviving the procedure, the middle bars the
percentage of cells that transiently express GFP measured via flow cytometry, and the bottom bar indicate the total percentage of viable GFP positive
cell in regards to the initial cell number (n=3 per platform, standard error). E) Representative flow cytometry plot for HUES9 cells expressing GFP after
electroporation. F) The table indicates the amount of colonies available for screening after a single electroporation per 10
6 cells and subsequent
antibiotic selection. G) Of these colonies, 85 were screened for successful gene targeting through homologous recombination via long range PCR.
doi:10.1371/journal.pone.0027495.g002
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Ethics statement
All animal procedures were approved by the Massachusetts
General Hospital subcommittee on research animal care under
animal protocols 2009N000050. Mice were maintained at a
barrier facility at the Centre for Regenerative Medicine,
Massachusetts General Hospital under a 12 hr light/12 hr dark
cycle at constant temperature (22uC) with free access to food and
water. All efforts were made to minimize suffering.
Maintenance of pluripotent cells
hESCs and hiPSCs were cultured feeder free on Geltrex
(Invitrogen) in the chemically defined medium mTESR1 (Stem
Cell Technologies). ECP passage: hPSCs were dissociated with
20% Accutase (StemProH) in PBS for 5–10 minutes at 37uC until
the cells could easily be detached with pipetting. Accutase was
removed and cells were replated in mTESR1 +0.4 mM ROCK-
Inhibitor (Y-27632 Cayman Chemical). ROCK-inhibitor was
removed 3–6 h after replating. SCP passage: hPSCs were
dissociated by adding Dispase StemCell Tech, 15–20 mg/
10 cm
2 plate and were incubated at 37uC for 3–5 minutes until
colony borders started to detach. After repeated washing with
DMEM cells were lifted with a cell scraper and the colonies
manually disrupted by pipetting several times.
Quantifcation of the cell viability
To measure the cell viability of the replating efficiency, freeze/
thawing and electroporation experiments, the cells were detached
with Accutase 2–3 h after being replating. The cells were counted
via Hausser Bright-Line Hemacytometer. All counting was done in
triplets.
Immunocytochemistry
The following antibodies were used: Immunostaining- a-SOX2
(Abcam ab15830, 1/200), a-TRA1-81 (Millipore, MAB4381, 1/
350), NANOG (Millipore, AB9220, 1/300), OCT3/4 (Abcam,
ab19857, 1/300), and Alexa Fluor secondary antibodies (Invitro-
gen). DAPI stain was used in a 1:5000 dilution to mark cell nuclei.
The Images were made either with a Nikon Digital Sight camera
mounted to a Nikon Eclipse Ti-S microscope or a Olympus DP72
camera mounted to a Olympus 1671 microscope. The software
packages NIS-Elements and Olympus DP2-BSW were used for
image analysis.
RNA extraction, cDNA synthesis, and quantitative RT-PCR
hPSCs were lysed in buffer RLT (Qiagen) with 1% b-
Mercaptoethanol and the total RNA purified via the RNeasy
mini kit (Qiagen) according to the manufacturer’s instructions.
The RNA yield was determined using the NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies) and 500 ng of total
RNA was further converted to cDNA using the Superscript First-
Strand Kit (Invitrogen). Quantitative RT-PCR was performed
using Quantifast-SYBR Green PCR mix (Qiagen) and the
Realplex Mastercycler (Eppendorf) with 25 ng of total RNA per
reaction. The reaction took place in the presence of Origene
STAR qPCR primer pairs against OCT3/4 (HP206340),
NANOG (HP215086) or NESTIN (HP209533).
Teratoma formation
For the teratoma assay, 5610
6 cells of either HUES9 or BJ
RiPSC were harvested, spun down, and all excess media was
removed. In a 20-week old female SCID mouse, the capsule of the
right kidney was gently elevated, and one droplet of concentrated
cells was inserted under the capsule. At week 6, when adequate
tumor size was observed, the tumor was harvested, fixed in 4%
Paraformaldehyde, run through an ethanol gradient, and stored in
70% ethanol. Specimens were sectioned and H&E staining. Slides
were imaged with a Leica light microscope.
Karyotyping
Cells were submitted to Cell Line Genetics for analysis.
Freeze/thawing
Cells were dissociated either through Accutase digest (ECP) or
by Dispase digest (SCP), transferred to mFreSRH (Stem Cell
Technologies) and immediately frozen down. After 2–3weeks in
liquid N2 the cells were thawed and plated on Geltrex coated
plates in either mTESR1 with 0.4 mM ROCK-Inhibitor (ECP) or
mTESR1 (SCP).
Limiting dilution assay
The various cell lines were diluted to a concentration of 0.5cell/
96well and two full 96well plates of each setup was prepared. After
7–10days the cells were fixated with 4% Paraformaldehyde,
analyzed via Immunocytochemistry and screened for colonies
expressing the pluripotency marker NANOG and OCT3/4.
Flow cytometry analysis
Cells were detached via Accutase digestion, and fixed for
20 minutes at 4uC in 2% Paraformaldehyde. The cells which were
subjected immunocytochemistry were initially counted and 16106
cells were transferred into polypropylene tubes. Staining for the
TRA1-60 antigen was performed using an antibody conjugated to
alexa fluor 488 (Biolegend, 330613) in 200 ml PBS with 5% FBS.
The cells were counted with a FACSCalibur flow cytometer (BD
Biosciences) and the data analyzed using the FlowJo software
package (Treestar).
Colony size measurement and variability
Images of random parts of the plate were made either with a
Nikon Digital Sight camera mounted to a Nikon Eclipse Ti-S
microscope. Three days after replating of single cells, 20 pictures
of random areas of the plates were taken and the colony sizes of
150 colonies of each platform were measured with the NIS
elements BR 3.10 software.
Production of lentivirus and transduction
We used a third-generation, Tat-free packaging system [14] to
produce recombinant lentivirus. The system consists of two
packaging plasmids—pMDL, pREV—, the plasmid coding for
VSV-G envelope and a vector for constitutive GFP under the
CMV promoter (LV-GFP). All four plasmids were transfected into
HEK293FT cells using calcium chlorate as previously reported
[15] and the viral supernatant was collected 48 and 72 hours later.
The supernatant was filtered through a 0.45 mm filter and the
RNA copy numbers per ml determined using the Lenti-X qRT-
PCR titration kit. For the transduction hPSCs were dissociated via
ECP/SCP and replated. Immediately after reattaching, approx-
imately 2 h after the replating, the lentivirus was added to the
plate and incubated for 2 hours at 37uC. The viral supernatant
was then removed, and cells were washed with DMEM and
mTESR1 was added. 48 hours after transduction the cells were
collected, fixed and analyzed for GFP expression via flow
cytometry.
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The Cells were detached with either Accutase or Dispase
filtered through a 40 mm cell strainer (BD Falcon) and counted.
40 mg of linearized DNA (EP-GFP) were mixed with 3610
6 cells in
800 ml PBS. An electric pulse was given in a 0.4 cm cuvette (Bio-
Rad Gene PulserH) with 320 V/200 mF [16]. The cells were
recovered and plated on Geltrex coated plates in TeSR and
0.4 mM/ml ROCK-Inhibitor. Viability and efficiency was deter-
mined 24 h after electroporation via cell counting and flow
cytometry.
Cell-lines
The following human embryonic stem cells lines were used for
the experiments: HUES1, HUES2, HUES6, HUES8 and HUES9
all first described in Cowan et al., 2004. The following human
induced pluripotent stem cell lines were used for the experiments:
BJ RiPSC and CF RiPSC first described by Warren et al., 2010.
The HEK293FT cell line used for Lenti-Virus production is
distributed Invitrogen (R700-07).
Supporting Information
Figure S1 Long term culture of hPSCs with ECP dosn’t
effect pluripotency and Karyotype. HUES9 and BJ RiPSC
cells were cultured 15 consecutive times with the ECP and
analyzed for pluripotency via A) Immunohistochemistry with the
indicated antibodies; nuclei were visualized with DAPI stain, via
B) quantitive reverse transcription real time PCR for OCT3/4,
NANOG and the negative control NESTIN a neural progenitor
cell marker (normalized to HPRT)(n=3), via C) Teratomaforma-
tion of HUES9 hESCs in immunodeficient SCID mice (black
arrow top left indicates neural rosette; black arrow top right -
pigmented epithelia, grey arrow top right gut-like epithelia;
bottom left- muscle-like tissue; black arrow bottom right cartilage).
D) Cell Karyotype of HUES9 hESCs after 196passages.
(TIF)
Figure S2 The influence of ROCK-Inhibitor. A) The
amount of cells reattached were determined 2 h after passage in
a total of 5 cell lines either using the SCP or ECP each with and
without 0.4 mM of ROCK-Inhibitor (n=3 per cell line, standard
error). B) Quantification of cells reattached after being frozen in
liquid nitrogen for 7–10 d and subsequently thawed in the
presence or absence of 0.4 mM of ROCK-Inhibitor (n=3 per
cell line, standard error). C) Determination of the clonogenic
potential, through a limiting dilution assay on a total of 3 cell lines
was performed with and without the addition of 0.4 mMo f
ROCK-Inhibitor (96 cell plated per cell line, standard error).
Counted were only colonies with positive immune-fluorescence
staining for the pluripotency markers OCT3/4 and NANOG.
(TIF)
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